Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
Hong Kong · Delayed Price · Currency is HKD 4.370
-0.160 (-3.53%)
Jun 18, 2026, 2:05 PM HKT
HKG:1167 Market Cap
HKG:1167 has a market cap or net worth of 3.55 billion as of June 17, 2026. Its market cap has decreased by -8.14% in one year.
Market Cap
3.55B
Enterprise Value
2.47B
Revenue
59.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.37
Market Cap Chart
Since December 21, 2020, HKG:1167's market cap has decreased from 10.95B to 3.55B, a decrease of -67.59%. That is a compound annual growth rate of -18.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 3.55B | -29.19% |
| Dec 31, 2025 | 5.01B | 400.46% |
| Dec 31, 2024 | 1.00B | -65.05% |
| Dec 29, 2023 | 2.87B | -28.96% |
| Dec 30, 2022 | 4.03B | -63.93% |
| Dec 31, 2021 | 11.19B | 3.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocumension Therapeutics | 4.06B |
| Guangzhou Innogen Pharmaceutical Group | 3.69B |
| Mirxes Holding Company | 3.66B |
| Laekna | 3.49B |
| Medtide | 3.45B |
| Qyuns Therapeutics | 3.41B |
| Jiangsu Recbio Technology | 2.97B |
| Shandong Boan Biotechnology | 2.91B |